Neurology · PANCE / PANRE

Tension-Type Headache

Most common primary headache; bilateral pressing/tightening, mild-moderate, no nausea.

Also known as: TTH, tension headache, muscle contraction headache, stress headache

Overview

Primary headache disorder characterized by bilateral, pressing or tightening (non-pulsating), mild-to-moderate intensity pain lasting 30 minutes to 7 days, without nausea/vomiting and with at most one of photophobia or phonophobia. Subclassified by frequency: infrequent episodic (<1 day/month), frequent episodic (1-14 days/month), and chronic (≥15 days/month for >3 months).

Epidemiology

Lifetime prevalence 30-78% — the most common primary headache disorder. Slight female predominance. Onset typically in teens through 30s.

Try a board-style Tension-Type Headache question

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1NeurologyMedium
A 28-year-old woman presents with a 6-month history of bilateral, band-like, pressing (non-pulsatile) headaches occurring 2-3 times per week and lasting 4-6 hours. The pain is mild to moderate, is not worsened by routine activity, and is not associated with nausea, vomiting, photophobia, or phonophobia. Neurologic exam is normal. She has not previously tried any therapy. Which of the following is the most appropriate first-line treatment for her acute headaches?
  • AOral ibuprofen
  • BOral sumatriptan
  • COral verapamil
  • DHigh-flow oxygen
Reveal answer & full explanation
Correct answer: A — Oral ibuprofen
  • AOral ibuprofen
  • BOral sumatriptan
  • COral verapamil
  • DHigh-flow oxygen

Why oral ibuprofen is correct

  • Episodic tension-type headache is the most common primary headache disorder: bilateral, pressing or tightening (non-pulsatile) pain of mild to moderate intensity, not aggravated by routine physical activity, and without nausea or significant photophobia/phonophobia
  • First-line acute therapy is a simple analgesic — NSAIDs (ibuprofen, naproxen) or acetaminophen — with NSAIDs generally preferred for efficacy, per current AAFP and international headache society guidance
  • Patients should be counseled to limit use to fewer than 10–15 days/month to avoid medication-overuse headache

Why the others are wrong

  • Oral sumatriptan — 5-HT1B/1D agonist for acute migraine; triptans are not effective for tension-type headache. Trap: buzzword-matching recurrent headache to migraine despite the stem excluding every migraine feature (pulsatile quality, nausea, photophobia/phonophobia, activity aggravation)
  • Oral verapamil — calcium channel blocker used for cluster headache prophylaxis; it is neither an acute therapy nor a tension-type headache drug. Trap: right-drug-wrong-disease plus prophylaxis-versus-acute confusion
  • High-flow oxygen — 12–15 L/min via nonrebreather is acute therapy for cluster headache, which causes severe unilateral periorbital pain with autonomic features — the opposite of this bilateral, mild, featureless pattern. Trap: confused-with-cluster

Additional high-yield points

  • For frequent or chronic tension-type headache, amitriptyline is first-line prophylaxis
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Tension-Type Headache outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Stress, anxiety, depression
  • Poor posture, prolonged static positions (computer work)
  • Sleep disturbance
  • Skipped meals, dehydration
  • Muscle tension in pericranial and cervical muscles
  • Caffeine overuse / withdrawal
  • Medication overuse (>15 days/month of analgesics)

Pathophysiology

Peripheral mechanisms include increased pericranial muscle tenderness from local nociceptor activation. Central mechanisms predominate in chronic forms: central sensitization at the level of the trigeminocervical complex amplifies pain perception. Genetic factors play a smaller role than in migraine.

Clinical presentation

Symptoms

  • Bilateral 'band-like' pressing or tightening pain
  • Mild to moderate intensity (does not preclude activities)
  • Duration 30 min to 7 days
  • NO nausea/vomiting
  • At most one of photophobia or phonophobia
  • Not aggravated by routine physical activity (unlike migraine)

Signs / physical exam

  • Generally normal neurologic exam
  • Pericranial tenderness on palpation (temporalis, frontalis, occipitalis, trapezius)
  • Possible cervical paraspinal tenderness, limited cervical ROM

Classic findings

Bilateral, non-throbbing, mild-moderate, without autonomic or migrainous features.

Differential diagnosis

  • Migraine — Unilateral, pulsating, moderate-severe, with nausea/photo/phonophobia, worse with activity
  • Cluster headache — Severe unilateral periorbital, autonomic features, episodic timing, restlessness
  • Medication overuse headache — Daily/near-daily headache with frequent acute medication use
  • Cervicogenic headache — Mechanical neck pain reproducing the headache; unilateral; limited cervical ROM
  • Sinus headache — Facial pressure with nasal congestion/discharge, worse bending forward, fever; though true 'sinus headache' is over-diagnosed and many cases are migraine
  • Temporomandibular disorder — Jaw pain, clicking, bruxism; tenderness over TMJ
  • Secondary causes (mass, IIH, GCA) — Atypical features, focal deficit, age >50 with new headache, papilledema

Diagnostic workup

Diagnostic criteria

ICHD-3: ≥10 episodes lasting 30 min-7 days, with ≥2 of [bilateral, pressing/tightening, mild-moderate, not aggravated by activity] AND no nausea/vomiting AND ≤1 of [photophobia, phonophobia].

Labs

  • Not routinely indicated
  • ESR/CRP if temporal arteritis suspected (age >50)

Imaging

  • Not indicated for typical TTH with normal exam
  • MRI brain only if red flags (SNOOP — systemic, neurologic, onset, older age, pattern change)

Diagnostic algorithm

FeatureTension-TypeMigraine
LocationBilateral, band-likeUnilateral (60%)
QualityPressing, tightening (non-pulsatile)Throbbing, pulsating
IntensityMild to moderateModerate to severe
Duration30 min to 7 days4-72 hours
Aggravation by activityNoYes
Nausea / vomitingAbsentPresent
Photo / phonophobia0 or 1 of themBoth common
First-line acute RxNSAID, acetaminophenNSAID, triptan, gepant
First-line preventionAmitriptylinePropranolol, topiramate, CGRP mAb
Tension-type headache vs. migraine — key distinguishing features.

Treatment

First-line

  • NSAIDs — ibuprofen 400-800 mg, naproxen 500 mg — first-line for acute treatment
  • Acetaminophen 1000 mg — alternative; less effective than NSAIDs
  • Aspirin 650-1000 mg
  • Combination analgesics (acetaminophen-aspirin-caffeine) — effective but increase risk of medication overuse headache
  • Limit acute medications to <2 days/week to prevent medication overuse headache

Second-line / adjunct

  • Prophylaxis indicated for chronic TTH (≥15 days/month) or frequent episodic TTH that interferes with QOL
  • Tricyclic antidepressant — amitriptyline 10-75 mg at bedtime (first-line for chronic TTH) — start low, titrate
  • Mirtazapine 15-30 mg or venlafaxine 75-150 mg — alternatives
  • Non-pharmacologic: relaxation training, biofeedback, cognitive-behavioral therapy, physical therapy with stretching, posture training, acupuncture
  • Trigger management: stress reduction, regular sleep, hydration, regular meals, ergonomic workspace
  • Address comorbid depression/anxiety

Complications

  • Chronic transformation (episodic → chronic TTH)
  • Medication overuse headache
  • Reduced quality of life, work productivity loss
  • Comorbid depression and anxiety
  • Overlap with migraine (mixed headache disorder)

PANCE pearls

  • If the patient describes a headache severe enough to keep them from work or causes nausea, it is probably migraine — not TTH.
  • Tricyclic antidepressants (amitriptyline) are the most effective preventive medication for chronic TTH.
  • Non-pharmacologic therapies (relaxation, CBT, PT) have strong evidence and should be offered to all chronic TTH patients.
  • Frequent use of acute medications (>2 days/week, especially combination analgesics with caffeine) drives medication overuse headache.
  • Always reconsider the diagnosis if 'TTH' worsens, becomes unilateral, or develops new features — could be evolving migraine or secondary cause.

References

  • AAN/AHS — Evidence-based Guideline Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults (Silberstein et al., Neurology 2012) — chronic TTH treatment evidence reviewed concurrently
  • ICHD-3 — International Classification of Headache Disorders, 3rd edition (HCC of IHS, Cephalalgia 2018)
  • EFNS Guideline — EFNS Guideline on the Treatment of Tension-Type Headache (Bendtsen et al., Eur J Neurol 2010)

Practice Neurology questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the free question above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.